Tanta University: Peripheral Nervous System Diseases trials
The registry lists 10 Peripheral Nervous System Diseases studies with Tanta University as lead sponsor. 3 are open to participants now and 0 have results posted.
Early Phase 1 1Phase 1 1Phase 2 3Phase 3 4Phase 4 2No phase 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Neuroprotection of Memantine and RosuvastatinNot yet recruitingNCT07504198Phase 2/3
- Fenofibrate Role in the Prophylaxis From Peripheral Neuropathy Induced by Bortezomib, Lenalidomide and Dexamethasone (VRd) Protocol in the Treatment of Patients With Multiple Myeloma (MM)RecruitingNCT07025005Phase 4
- The Possible Protective Role of Ketotifen Against Oxaliplatin Induced Peripheral NeuropathyRecruitingNCT05624138Phase 3
- Protective Effect of N-acetylcysteine on Oxaliplatin-Induced Neuropathy in Colorectal CancerCompletedNCT07391163Not applicable
- Diabetic Small Fiber Neuropathy: Clinical, Electrophysiological and Neurosonographic StudyCompletedNCT05993871
- Empagliflozin in Treatment of Peripheral Diabetic NeuropathyCompletedNCT05977465Phase 1/2
- Role of Silymarin in Chemotherapy Toxicity and Cognition Improvement in Breast Cancer PatientsStatus unknownNCT05595109Phase 2/3
- Protective Effect of Pentoxifylline Against Chemotherapy Induced Toxicities in Patients With Colorectal CancerStatus unknownNCT05590117Early Phase 1
- Comparative Clinical Study Evaluating the Possible Efficacy of Duloxetine, Gabapentin and Lacosamide on Oxaliplatin-Induced Peripheral Neuropathy in Cancer PatientsCompletedNCT05510856Phase 4
- Clinical Study Evaluating the Safety and Efficacy of Roflumilast in Type 2 Diabetic Patients With Diabetic NeuropathyCompletedNCT05369793Phase 3